Background:
The aberrant alteration in Jab1 signalosome (COP9 Signalosome Complex Subunit 5)
has been proven to be associated with the progression of several carcinomas. However the specific role and
mechanism of action of Jab1 signalosome in carcinogenesis of gall bladder cancer (GBC) are poorly understood.
Objective:
The main objective of our study was to elucidate the role and mechanism of Jab1 signalosome in gall
bladder cancer by employing siRNA.
Methods:
Jab1 overexpression was identified in gall bladder cancer tissue sample. The role of Jab1-siRNA
approach in cell growth inhibition and apoptotic induction was then examined by RT-PCR, Western Blotting,
MTT, ROS, Hoechst and FITC/Annexin-V staining.
Results:
In the current study, we have shown that overexpression of Jab1 stimulated the proliferation of GBC
cells; whereas downregulation of Jab1 by using Jab1-siRNA approach resulted incell growth inhibition and
apoptotic induction. Furthermore, we found that downregulation of Jab1 induces cell cycle arrest at G1 phase
and upregulated the expression of p27, p53 and Bax gene. Moreover, Jab1-siRNA induces apoptosis by enhancing
ROS generation and caspase-3 activation. In addition, combined treatment with Jab1-siRNA and gemicitabine
demonstrated an enhanced decline in cell proliferation which further suggested increased efficacy of gemcitabine
at a very lower dose (5μM) in combination with Jab1-siRNA.
Conclusion:
In conclusion, our study strongly suggests that targeting Jab1 signalosome could be a promising
therapeutic target for the treatment of gall bladder cancer.
Cell Growth Inhibition and Transglutaminase 2 Expression in Human Erythroleukemia Cells (K562) Following Exposure to Retinoic Acid and Sodium Butyrate
